$1.71
-0.01-0.58%
At Close: -
$1.70
-0.0090-0.53%
After Hours: Sep 20, 9:27 AM EDT
15 minutes delayed
TherapeuticsMD reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TherapeuticsMD using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $-0.13 | $-0.05 | -160.0 % |
Jun 2023 | 2023-08-14 | $-0.24 | $-0.07 | -242.9 % |
Mar 2023 | 2023-05-15 | $-0.24 | $0.06 | -500.0 % |
Mar 2023 | 2023-04-07 | $-3.62 | $-1.11 | -226.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $-53.00K | $500.00K | -110.6 % |
Jun 2023 | 2023-08-14 | $437.00K | $500.00K | -12.6 % |
Mar 2023 | 2023-05-15 | $416.00K | $1.70M | -75.5 % |
Mar 2023 | 2023-04-07 | $1.15M | $23.80M | -95.2 % |
TherapeuticsMD (TXMD) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.09, which missed the estimate of $0.00.
The Actual Revenue was $234K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.